A new laboratory analysis of commercially available mRNA COVID-19 vaccines found that residual DNA fragments — including sequences linked to the spike protein gene — remain in the final vaccine products. The researchers concluded that commonly used quality-control tests can underestimate total residual DNA by more than 100-fold, because the tests fail to detect DNA bound in RNA:DNA hybrid structures.